NCT01736059Active, not recruitingPhase 1
Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy
A Pilot Clinical Trial of the Feasibility and Safety of Intravitreal Autologous Adult Bone Marrow Stem Cells in Treating Eyes With Vision Loss From Retinopathy
Source: ClinicalTrials.gov · Last updated 29 Jan 2026
Brief summary (registry, in English)
This pilot study is to determine whether it would be safe and feasible to inject CD34+ stem cells from bone marrow into the eye as treatment for patients who are irreversibly blind from various retinal conditions.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 25 Jul 2012
- Start date
- Jul 2012
- Primary completion date
- Oct 2026
- Lead sponsor
- University of California, Davis
- NCT number
- NCT01736059
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 15
- From Jul 2012 to the primary completion date, Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- other concurrent retinal or optic nerve disease affecting vision
Other illness
- allergy to fluorescein dye
Who the study is looking for
- age \>18 years of age
- visual acuity 20/100 to CF
- duration of vision loss \> 3 months
- vision loss from macular degeneration, retinitis pigmentosa, retinal vein occlusion or diabetic retinopathy
- the study eye has the worse visual acuity
- no active eye or systemic disease
- no history of macular edema or retinal/choroidal neovascularization requiring treatment within 6 months
- no significant media opacity
- no coagulopathy or other hematologic abnormality
- no concurrent immunosuppressive therapy
- able to keep follow-up for 6 months
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California - Davis Coordinator of this site? Confirm its status | Sacramento | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.